We next assessed the protective effects of mesaconine against myocardial injury by detecting the relative mRNA expression of atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), which are the primary diagnostic and predictive markers in heart failure. The gene discussed is NPPB; the disease is heart failure.